Diagnosis of patients with suspected chronic hepatitis C infection

Adrián Gadano1, Omar Galdame, Sebastián Marciano

  • 1Sección Hepatología, Hospital Italiano de Buenos Aires-Argentina, Ciudad de Buenos Aires, Argentina. adrian.gadano@hospitalitaliano.org.ar

Annals of Hepatology
|August 18, 2010
PubMed

Insights

Detecting hepatitis C virus (HCV) involves risk factor screening. Current tests diagnose and monitor treatment but do not assess disease severity or prognosis for HCV infection.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection is primarily detected through risk-based screening.
  • Transmission routes include blood transfusions, unsafe injections, and intravenous drug use.
  • Current diagnostic strategies focus on identifying at-risk populations for targeted testing.

Purpose of the Study:

  • To outline the optimal approach for detecting hepatitis C virus (HCV) infection.
  • To detail the available virological markers for clinical management.
  • To clarify the limitations of current diagnostic and monitoring tools.

Main Methods:

  • Review of current screening protocols for HCV infection.
  • Analysis of serologic assays (ELISA, immunoblot) for anti-HCV antibodies.
  • Evaluation of virological assays for serum HCV RNA detection (qualitative and quantitative).

Main Results:

  • Optimal HCV detection relies on screening individuals with identified risk factors.
  • Serologic and virologic assays are effective for diagnosis and treatment monitoring.
  • These tests do not provide information on disease severity or patient prognosis.

Conclusions:

  • Risk-factor-based screening remains the primary strategy for HCV detection.
  • Existing assays are crucial for diagnosis and monitoring but limited in prognostic assessment.
  • Patient education on preventing disease spread is essential post-diagnosis.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...